Suppr超能文献

心脏CT速率控制方案的安全性与有效性

Safety and efficacy of a rate control protocol for cardiac CT.

作者信息

Roberts W T, Wright A R, Timmis J B, Timmis A D

机构信息

The Hospital of St John and St Elizabeth, 60 Grove End Road, St John's Wood, London NW8 9NH, UK.

出版信息

Br J Radiol. 2009 Apr;82(976):267-71. doi: 10.1259/bjr/24574758. Epub 2008 Dec 19.

Abstract

The clinical application of cardiac CT is increasing, but heart rate control is often required to prevent motion artefact. Here, we describe a protocol for heart rate control in patients undergoing outpatient CT coronary angiography (CTCA). Among 121 consecutive patients, 75 (61.9%) with a resting heart rate >60 beats per minute (bpm) required rate control medication. Our protocol called for oral metoprolol 100 mg to be given 60 min before scanning, with patients for whom beta-blockers were contraindicated receiving 240 mg oral verapamil. Additional 5 mg intravenous boluses (maximum for both drugs, 15 mg) were given if the heart rate remained >60 bpm prior to scanning. Of 71 patients treated with oral metoprolol, 59 (83%) achieved a rate <or=65 bpm and 46 (65%) achieved a heart rate of <or=60 bpm during the CTCA scan. All four patients receiving verapamil had a poor rate response and had heart rates >70 bpm at the time of scanning. No adverse events resulted from rate control medication. Image quality was closely related to heart rate. Severe motion artefact (Grade 3) occurred in only 0.9% of patients with a rate <or=60 bpm compared with 50% of patients with a rate >70 bpm. In conclusion, the administration of oral metoprolol according to the described protocol is a safe and effective way of reducing heart rate and improving scan quality in the majority of patients undergoing CTCA.

摘要

心脏CT的临床应用正在增加,但通常需要控制心率以防止运动伪影。在此,我们描述了一种在接受门诊CT冠状动脉造影(CTCA)的患者中控制心率的方案。在121例连续患者中,75例(61.9%)静息心率>60次/分钟(bpm)的患者需要使用控制心率的药物。我们的方案要求在扫描前60分钟口服100mg美托洛尔,对于β受体阻滞剂禁忌的患者给予240mg口服维拉帕米。如果扫描前心率仍>60bpm,则额外静脉推注5mg(两种药物最大剂量均为15mg)。在71例接受口服美托洛尔治疗的患者中,59例(83%)在CTCA扫描期间心率≤65bpm,46例(65%)心率≤60bpm。所有4例接受维拉帕米治疗的患者心率控制效果不佳,扫描时心率>70bpm。控制心率的药物未导致不良事件。图像质量与心率密切相关。心率≤60bpm的患者中仅0.9%出现严重运动伪影(3级),而心率>70bpm的患者中这一比例为50%。总之,按照所述方案给予口服美托洛尔是降低大多数接受CTCA患者心率并提高扫描质量的一种安全有效的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验